Pulmonary Hypertensive Diseases (Q70322974)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6365477%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

Pulmonary hypertensive diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6365477%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Pulmonary Hypertensive Diseases (English)

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

9 October 2023

main subject

pulmonary hypertension

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6365477

Cardiology and cardiovascular medicine

9 October 2023

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

9 October 2023

author name string

S. Rounds

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6365477

9 October 2023

N. S. Hill

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6365477

9 October 2023

publication date

1 March 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6365477%20AND%20SRC:MED&resulttype=core&format=json

https://api.elsevier.com/content/article/PII:S0012369215402351?httpAccept=text/xml

10 October 2019

language of work or name

English

0 references

work available at URL

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

https://api.elsevier.com/content/article/PII:S0012369215402351?httpAccept=text/plain

9 October 2023

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

9 October 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6365477%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6365477%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6365477%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

397-405

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6365477%20AND%20SRC:MED&resulttype=core&format=json

publication type of scholarly work

10 October 2019

review article

1 reference

Primary pulmonary hypertension

cites work

2

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease

9 October 2023

4

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Hypoxia on the pulmonary circulation. How and where it acts

9 October 2023

5

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Release of vasodilator prostaglandin, PGI2, from isolated rat lung during vasoconstriction

9 October 2023

6

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Nonimmunological production of leukotrienes induced by platelet-activating factor

9 October 2023

7

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features

9 October 2023

8

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Pulmonary vascular disease with congenital heart lesions: pathologic features and causes

9 October 2023

11

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Pulmonary vasoconstriction in steers at high altitude

9 October 2023

12

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

The genetic factor influencing pulmonary hypertension in cattle at high altitude

9 October 2023

13

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Lung vascular smooth muscle as a determinant of pulmonary hypertension at high altitude

9 October 2023

14

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery

9 October 2023

15

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Collateral ventilation may protect against high-altitude pulmonary hypertension

9 October 2023

16

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Blunted hypoxic vasoconstriction in lungs from short-term high-altitude rats

9 October 2023

18

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

The effect of oxygen on Cor pulmonale in experimental emphysema induced by elastase or elastase and beta-aminopropionitrile in hamsters

9 October 2023

19

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Development of Crotalaria pulmonary hypertension: hemodynamic and structural study

9 October 2023

20

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Alpha-naphthyl-thiourea-induced pulmonary oedema in the rat: a topographical and electron-microscope study

9 October 2023

21

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Increased pulmonary microvasuclar permeability induced by alpha-naphthylthiourea

9 October 2023

22

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Vascular reactivity is increased in rat lungs injured with alpha-naphthylthiourea

9 October 2023

24

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Identification of pulmonary hypertension in chronic obstructive pulmonary disease from routine chest radiographs

9 October 2023

26

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Electrocardiogram in chronic cor pulmonale

9 October 2023

27

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Echocardiographic features of primary pulmonary hypertension

9 October 2023

28

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease

9 October 2023

29

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Peripheral airways obstruction in idiopathic pulmonary artery hypertension (primary).

9 October 2023

31

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Cardiovascular performance in chronic obstructive pulmonary diseases.

9 October 2023

32

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Fatal Lung Scan in a Case of Pulmonary Hypertension due to Obliterative Pulmonary Vascular Disease

9 October 2023

33

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Magnification pulmonary wedge angiography in the evaluation of children with congenital heart disease and pulmonary hypertension

9 October 2023

35

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Lung biopsy specimens in the evaluation of pulmonary vascular disease

9 October 2023

36

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Hemodynamic effects of staged hematocrit reduction in patients with stable cor pulmonale and severely elevated hematocrit levels

9 October 2023

37

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group

9 October 2023

39

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

The Veterans Administration cooperative study of pulmonary function. 3. Mortality in relation to respiratory function in chronic obstructive pulmonary disease

9 October 2023

40

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Relation of oxygen delivery, mixed venous oxygenation, and pulmonary hemodynamics to prognosis in chronic obstructive pulmonary disease

9 October 2023

41

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Early effects of oxygen administration and prognosis in chronic obstructive pulmonary disease and cor pulmonale

9 October 2023

42

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Effect of intravenous terbutaline on arterial blood gas tensions, ventilation, and pulmonary circulation in patients with chronic bronchitis and cor pulmonale

9 October 2023

43

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Haemodynamic effects of phentolamine in chronic obstructive pulmonary disease

9 October 2023

44

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Effects of isosorbide dinitrate on pulmonary hypertension in chronic obstructive pulmonary disease

9 October 2023

45

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale

9 October 2023

46

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension

9 October 2023

47

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Primary pulmonary hypertension: report of six cases and review of literature

9 October 2023

48

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Primary pulmonary hypertension. Effect of unilateral pulmonary artery occlusion and infusion of acetylcholine

9 October 2023

49

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Primary Pulmonary Hypertension Treated with Oral Phentolamine

9 October 2023

50

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Diazoxide in primary pulmonary hypertension

9 October 2023

51

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Oral hydralazine therapy for primary pulmonary hypertension

9 October 2023

52

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Deleterious effects of hydralazine in patients with pulmonary hypertension

9 October 2023

53

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause

9 October 2023

54

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment

9 October 2023

55

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Hazards of diazoxide in pulmonary hypertension

9 October 2023

57

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension

9 October 2023

58

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Primary pulmonary hypertension: beneficial therapy with diltiazem

9 October 2023

59

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Primary pulmonary hypertension: effects of nifedipine

9 October 2023

60

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Verapamil and Pulmonary Hypertension

9 October 2023

61

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Captopril in primary pulmonary hypertension

9 October 2023

62

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response

9 October 2023

63

1 reference

https://api.crossref.org/works/10.1378/CHEST.85.3.397

9 October 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6365477%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference